TD Cowen is managing a share offering for PMV Pharma, which has been filed with the SEC and utilizes Broadridge Financial Solutions for mailing the prospectus.

The entities involved

• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12
• Broadridge Financial Solutions →

  American corporate services company

  • SEC is overseeing public offering filings involving Broadridge Financial Solutions.Sun 21:17
  • Trump's pledge to unleash oil and gas benefits certain stocks.Sun 02:30

Related events

• TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.Aug 27
• TD Cowen provided analyst ratings and price targets for Ardelyx, accompanied by required stock transaction filings with the SEC.Aug 26
• TD Cowen and Royal Bank of Canada published research reports on ChargePoint shares.Sep 23
• TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.Aug 18
• TD Cowen boosted its price objective on Elevance Health, while the National Pension Service reduced its holdings and filed 13F with the SEC.Sep 11